Table 4.
Incidence (per million person-years) of Primary Soft Tissue by Histologic Subtype and Topography subgroup, Iran (2009-2014)
Histology Subgroup | C49.1 | C49.2 | C49.5 |
Total | 15.41 (15.28-15.53) | 36.70 (36.51-36.89) | 10.30 (10.20-10.41) |
Paragangliomas and Glomous Tumors | 0.00 (0.00-0.00) | 0.03 (0.02-0.03) | 0.00 (0.00-0.00) |
Soft Tissue Sarcomas, NOS | 5.24 (5.17-5.31) | 11.17 (11.06-11.27) | 4.24 (4.18-4.31) |
Fibromatous Sarcomas | 3.32 (3.26-3.37) | 7.45 (7.36-7.54) | 1.41 (1.38-1.45) |
Myxomatous Sarcomas | 0.05 (0.04-0.05) | 0.10 (0.08-0.11) | 0.00 (0.00-0.00) |
Lipomatous Sarcomas | 1.34 (1.30-1.37) | 6.09 (6.02-6.17) | 1.72 (1.68-1.76) |
Myomatous Sarcomas | 1.31 (1.27-1.35) | 2.68 (2.63-2.73) | 1.54 (1.50-1.58) |
Complex Mixed Sarcomas | 0.05 (0.04-0.05) | 0.13 (0.12-0.15) | 0.02 (0.01-0.02) |
Synovial Like Sarcomas | 1.84 (1.80-1.88) | 5.35 (5.28-5.42) | 0.65 (0.63-0.67) |
Blood Vessels Sarcomas | 0.67 (0.64-0.70) | 0.90 (0.86-0.93) | 0.08 (0.07-0.09) |
Lymphatic Vessels Sarcomas | 0.03 (0.03-0.04) | 0.03 (0.02-0.03) | 0.00 (0.00-0.00) |
Giant Cell Tumors-Malignant | 0.73 (0.70-0.76) | 0.22 (0.21-0.24) | 0.03 (0.02-0.03) |
Ewing tumor and Askin tumor of soft tissue | 0.30 (0.29-0.32) | 0.77 (0.74-0.79) | 0.30 (0.28-0.31) |